Global Lithotripsy Devices Market is segmented By Type (Extracorporeal Shock Wave Lithotripsy Devices, Intracorporeal Lithotripsy Devices),By Application (Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Market Overview
Global Lithotripsy Devices Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
Lithotripsy devices are medical devices or machines used in urology and nephrology for carrying out lithotripsy, a non-invasive medical procedure intended to break down and fragment stones or calculi that form in different areas of the urinary tract, such as the kidneys, ureter, or bladder.
Lithotripsy devices serve as essential devices in research and training settings for examining stone fragmentation techniques and educating healthcare professionals on their use, emphasizing their versatility in improving patient care and medical practice.
The lithotripsy devices market has grown significantly in recent years as a result of technological advancements and an increase in cases of urolithiasis and other urinary tract diseases.
Market Scope
| Metrics | Details |
| CAGR | YY% |
| Size Available for Years | 2021-2030 |
| Forecast Period | 2023-2030 |
| Data Availability | Value (US$ Mn) |
| Segments Covered | Type, Application, End User |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics: Drivers and Restraints
The continuous advancements in lithotripsy devices
The lithotripsy devices market is expected to drive the market owing to the ongoing technological improvements. These developments are transforming the fields of urology and nephrology, improving the efficacy and safety of lithotripsy procedures, and driving market growth.
For instance, in February 2022, Applaud Medical obtained a Breakthrough Device Designation from the FDA for its Acoustic Enhancer technology. This innovation is intended to be used in combination with ureteroscopy with laser lithotripsy (URS-LL) to break down calcium-based kidney stones ranging in size from 6 mm to 20 mm. The Acoustic Enhancer is a small bubble filled with gas and covered by a lipid shell that has been specially designed for this purpose.
Furthermore, in February 2021, The US Food and Drug Administration (FDA) has approved the Shockwave intravascular lithotripsy (IVL) system for the treatment of highly calcified coronary arterial plaques. This device uses a balloon to provide sonic pressure waves capable of passing through soft artery tissue, with the main objective of selectively breaking down calcified plaque to improve stent insertion.
Furthermore, the increasing prevalence of urolithiasis and urinary tract disorders and aging population are some of the other major factors that are expected to drive the global lithotripsy devices market over the forecast period.
Market Dynamics: Restraint
The high cost associated with the lithotripsy devices is major restraint for this market, especially in developing countries with limited access to healthcare insurance. For instance, according to Australian Institute of Health and Welfare 2023 article, the average cost of lithotripsy of bile duct stones may range within $2,100-3,300.
Furthermore, the side effects and complications associated with the lithotripsy procedures causing pain, bruising, and the risk of renal injury and and the availability of alternative treatments for stone removal are the factors that will restrain the market over the forecast period.
Market Segment Analysis
The global lithotripsy devices is segmented based on type, application, end user and region.
The extracorporeal shock wave lithotripsy devices segment accounted for approximately 54.2 % of the market share
The extracorporeal shock wave lithotripsy devices segment accounted for 54.2% and it is expected to be dominated during the forecast period. Extracorporeal shock wave lithotripsy is a technique that uses a lithotripter to produce a series of shock waves to break up stones in the urinary system, bile ducts, or pancreatic ducts. The segment is expected to drive owing to the increasing centers for lithotripsy and rising prevalence of kidney stones where extracorporeal shock wave lithotripsy devices play a major role.
For instance, in May 2023, the Government Kilpauk Medical College (KMC) Hospital launched an extracorporeal shock wave lithotripsy (ESWL) Treatment Center. MOBIS India Foundation financed the ESWL machine, which costs 2.3 crore, as part of its corporate social responsibility funding.
Furthermore, the rising prevalence of kidney stones is major driving factors for this segment. For instance, according to National Kidney Foundation article, approximately one in ten people is expected to have kidney stone at some stage of their life. Moreover, more than one million people go the emergency rooms for kidney stone every year. Thus, owing to the above factors the segment is expected to dominate over the forecast period.
Geographical Analysis
North America accounted for approximately 37.4% of the market share in 2022
North America is estimated to hold about 37.4% of the total market share throughout the forecast period, owing to the increasing number of investment, increasing prevalence of kidney disease, product approvals, rising geriatric population, collaboration with the key players, and others that will drive this region further during the forecast period.
For instance, Adventist Health Hanford invested about USD 250,000 in November 2022 to acquire the Lumenis Pulse 120H Holmium Laser System with MOSES Technology. This cutting-edge device not only allows for speedier surgeries, saving up to 20% of the time, but it also decreases anesthetic usage, promotes faster patient recovery, and allows for outpatient treatment without hospitalization.
Furthermore, according to the Centers for Disease Control and Prevention, around 37 million people, or one in every seven adults or 15% of the adult population, were expected to have chronic renal disease by July 2022. As the prevalence of kidney disease rises, more than 50,000 lithotripsy treatments are conducted in the U.S. each year, contributing to the growth of the lithotripsy device market over the forecast period.
COVID-19 Impact Analysis
The lithotripsy device market is expected to face a setback as a result of the COVID-19 outbreak. When the pandemic occurred, the growth of the lithotripsy device industry halted. Surgical operations and non-urgent medical treatments unrelated to COVID-19 were placed on hold or canceled for the time being.
For instance, Kidney Care UK provided data in March 2021 indicating that the National Health Service (NHS) disrupted the care of more than 56% of patients. Furthermore, the report indicated that more than 28% of patients were waiting for procedures and were unable to acquire basic appointments. Furthermore, more than 18% of patients experienced difficulty reaching their general practitioners or hospital teams for medical consultations, and more than 7% reported worsening health as a result of delayed care. However, the market is expected to be stable and grow over the period of time as the resumption of all services occurs.
Competitive Landscape
The major global players in the lithotripsy devices market include Olympus Corporation, Boston Scientific Corporation, NOVAMEDTEK, Inceler Medikal Co. Ltd., EDAP TMS, Advin Health Care, MTS Medical, STORZ MEDICAL AG, Shenzhen Huikang Medical Apparatus Co., Ltd., Medispec and among others.
Key Developments
- In May 2, 2023, the Government Kilpauk Medical College (KMC) Hospital launched an extracorporeal shock wave lithotripsy (ESWL) Treatment Center. MOBIS India Foundation financed the ESWL machine, which costs 2.3 crore, as part of its corporate social responsibility funding.
- In March 31, 2022, Shockwave Medical, Inc., a pioneer in the advancement of Intravascular Lithotripsy (IVL) for treating severely calcified cardiovascular disease, announced the global commercial availability of the Shockwave M5+ peripheral IVL catheter following CE Mark and FDA clearance. The Shockwave M5+ catheter, which has only recently been available, is specifically developed to reduce IVL treatment time, provide alternate access options, and expand IVL therapy to patients with larger vessel diameters.
Why Purchase the Report?
- To visualize the global lithotripsy devices market segmentation-based on type, application, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of lithotripsy devices market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global lithotripsy devices market report would provide approximately 77 tables, 77 figures, and 185 Pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
